Progyny, Inc. Files 8-K Report
Ticker: PGNY · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1551306
| Field | Detail |
|---|---|
| Company | Progyny, Inc. (PGNY) |
| Form Type | 8-K |
| Filed Date | Jan 13, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, filing, company-update
TL;DR
Progyny filed an 8-K on Jan 13, 2025 - something happened.
AI Summary
On January 13, 2025, Progyny, Inc. filed an 8-K report. The filing indicates a change in the company's status or operations, but the specific details of the event are not elaborated upon in the provided text. The report was filed with the SEC, as is standard for public companies.
Why It Matters
This filing signals a material event for Progyny, Inc. that requires public disclosure, potentially impacting investors' understanding of the company's current situation.
Risk Assessment
Risk Level: low — The filing is a standard procedural document (8-K) without immediate negative or positive financial implications detailed in the provided text.
Key Players & Entities
- Progyny, Inc. (company) — Registrant
- January 13, 2025 (date) — Date of earliest event reported
- Delaware (jurisdiction) — State of Incorporation
- 001-39100 (identifier) — Commission File Number
- 27-2220139 (identifier) — IRS Employer Identification No.
- 1359 Broadway New York, New York 10018 (address) — Address of Principal Executive Offices
- 212-888-3124 (phone_number) — Registrant's Telephone Number
- Auxogyn, Inc. (company) — Former Company Name
- 20150318 (date) — Date of Name Change from Auxogyn, Inc.
- Auxogyn Inc (company) — Former Company Name
FAQ
What specific event triggered this 8-K filing for Progyny, Inc. on January 13, 2025?
The provided text does not specify the exact event that triggered the 8-K filing, only that it was filed on January 13, 2025, and pertains to 'Results of Operations and Financial Condition'.
What is Progyny, Inc.'s principal executive office address?
Progyny, Inc.'s principal executive offices are located at 1359 Broadway, New York, New York 10018.
When did Progyny, Inc. change its name from Auxogyn, Inc.?
Progyny, Inc. changed its name from Auxogyn, Inc. on March 18, 2015.
What is Progyny, Inc.'s Commission File Number?
Progyny, Inc.'s Commission File Number is 001-39100.
What is the IRS Employer Identification Number for Progyny, Inc.?
The IRS Employer Identification Number for Progyny, Inc. is 27-2220139.
Filing Stats: 510 words · 2 min read · ~2 pages · Grade level 11.3 · Accepted 2025-01-13 08:04:59
Key Financial Figures
- $0.0001 — nge on which registered Common Stock , $0.0001 par value per share PGNY The Nasdaq Gl
Filing Documents
- pgny-20250113.htm (8-K) — 27KB
- a1132025-jpmorganpressrele.htm (EX-99.1) — 20KB
- 0001551306-25-000006.txt ( ) — 173KB
- pgny-20250113.xsd (EX-101.SCH) — 2KB
- pgny-20250113_lab.xml (EX-101.LAB) — 21KB
- pgny-20250113_pre.xml (EX-101.PRE) — 12KB
- pgny-20250113_htm.xml (XML) — 3KB
02 Results of Operations and Financial Condition
Item 2.02 Results of Operations and Financial Condition. On January 13, 2025, Progyny, Inc. (the "Company") issued a press release to update the Company's previously issued financial guidance for the three months and year ending December 31, 2024. A copy of this press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated by reference herein. The information furnished under this Item 2.02, including Exhibit 99.1, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or subject to the liabilities of that section. The information shall not be deemed incorporated by reference into any other filing with the Securities and Exchange Commission made by the Company, regardless of any general incorporation language in such filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Press Release of Progyny, Inc. dated January 13, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Progyny, Inc. Dated: January 13, 2025 By: /s/ Peter Anevski Peter Anevski Chief Executive Officer